ChemoMetec A/S (CHEMM)
Copenhagen Exchange · Denmark · prices in DKK · close of 22 Oct 2026
Key indicators
| Last close | DKK 595.00 |
|---|---|
| 52-week range | 235.20 – 804.00 |
| Return, 1 month / 3 months | +15.5% / +46.9% |
| Return, 1 year / 3 years | −12.8% / +117.2% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 71.7% |
| Worst drawdown (1 year) | -70.1% |
| Average daily value traded | 35.50M DKK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ChemoMetec makes automated instruments and consumables for counting and analysing cells. Its NucleoCounter systems are used by laboratories in biopharmaceutical production, life-science research and food and agricultural testing to measure cell concentration and viability. The company designs both the hardware and the sample slides that go with it, and it supplies customers such as pharmaceutical manufacturers, contract laboratories and research institutions. ChemoMetec is based in Allerød, Denmark, and serves markets internationally.
On this site ChemoMetec A/S appears as a stock on the Copenhagen Exchange (Denmark), code CHEMM, with prices in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ChemoMetec A/S (CHEMM) trades on the Copenhagen Exchange in Denmark. It last closed at DKK 595.00 on 22 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 73 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.8% and over the last three months it rose 46.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Copenhagen Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 34.0% | ||
| From 52-week high | -24.9% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 46.9% | ||
| 6-month return | 73.9% | ||
| 12-month return, skipping the last month | -24.5% | ||
| Stability (higher is calmer) | 7 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 71.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -70.1% | ||
| Liquidity | 83 · Strong | Trades actively. | |
| Average daily value traded | 35.50M DKK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +3.3% |
|---|---|
| 1 month | +15.5% |
| 3 months | +46.9% |
| 6 months | +73.9% |
| 1 year | −12.8% |
| 3 years | +117.2% |
| 5 years | −34.5% |
Signals
| 50-day / 200-day average | 523.97 / 444.13 |
|---|---|
| Golden / death cross (60 days) | Golden, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 19.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Oct 2025 | DKK 7.0000 |
| 11 Oct 2024 | DKK 4.0000 |
| 13 Oct 2023 | DKK 6.0000 |
| 15 Oct 2021 | DKK 4.0000 |
| 9 Oct 2020 | DKK 1.5000 |
| 14 Jan 2020 | DKK 13.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Copenhagen Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.